Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Basma H. Othman"'
Autor:
Basma H. Marghani, Mohamed El-Adl, Ahmed I. Ateya, Basma H. Othman, Heba I. Ghamry, Mustafa Shukry, Mohamed Mohamed Soliman, Mohamed Abdo Rizk
Publikováno v:
Metabolites, Vol 12, Iss 10, p 999 (2022)
Cyclosporine A (CSA) is an immunosuppressive drug that has improved transplant survival rates. However, its use is often limited because it is thought to be linked to the development of chronic kidney disease after kidney transplants. This study aime
Externí odkaz:
https://doaj.org/article/7eca4ab76b8e486cba76a62e6a72ab3f
Autor:
Hassan Reda Hassan Elsayed, Randa El-Gamal, Mohammed R. Rabei, Mona G. Elhadidy, Shereen Hamed, Basma H. Othman, Mohamed Mahmoud Abdelraheem Elshaer, Mostafa Khaled Sedky, Ahmed Tarek Abd Elbaset Hassan, Mohammad El-Nablaway
Publikováno v:
Cells, Vol 11, Iss 4, p 746 (2022)
Obesity causes renal changes (ORC), characterized by defective renal autophagy, lipogenesis, enhanced macrophage infiltration and apoptosis. We hypothesize that Dasatinib, a tyrosine kinase inhibitor, may ameliorate changes associated with obesity. W
Externí odkaz:
https://doaj.org/article/5b4415acc84d44049d59c695b9bf81a8
Autor:
Hassan Reda Hassan Elsayed, Randa El-Gamal, Mohammed R. Rabei, Mona G. Elhadidy, Shereen Hamed, Basma H. Othman, Mohamed Mahmoud Abdelraheem Elshaer, Mostafa Khaled Sedky, Ahmed Tarek Abd Elbaset Hassan, Mohammad El-Nablaway
Publikováno v:
Cells; Volume 11; Issue 4; Pages: 746
Obesity causes renal changes (ORC), characterized by defective renal autophagy, lipogenesis, enhanced macrophage infiltration and apoptosis. We hypothesize that Dasatinib, a tyrosine kinase inhibitor, may ameliorate changes associated with obesity. W
Publikováno v:
Mansoura Veterinary Medical Journal. 20:1-5
Mesenchymal stem cells (MSCs) have generated a great deal of excitement and promise as a potential source of all types of cells for cell-based therapeutic strategies. The present study aimed to evaluate the ameliorative effect of MSCs injected via ta
Autor:
Hassan Reda Hassan Elsayed, Mostafa Mohammed Abd-Elmonem, Randa El-Gamal, Eman Mohammad El Nashar, Mohammad El-Nablaway, Asim Mohammed Abdalla, Basma H. Othman
Publikováno v:
Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft. 234
Background Non-alcoholic fatty liver disease (NAFLD) is a worldwide disease that progresses into steatohepatitis (NASH) that has no current effective treatment. This study aimed, for the first time, to investigate the effect of Dasatinib; a tyrosine